—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Gilead Sciences Inc (GILD) — Technical state

As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +14.6% vs the 50-day and +24.3% vs the 200-day average, 0.7% below the 52-week high and +50.8% off the 52-week low; a golden cross printed 50 sessions ago. Computed from daily closes. (as of 2026-11-04)
  • Trend: Gilead Sciences Inc trades 14.6% above its 50-day and 24.3% above its 200-day moving average. (as of 2026-11-04)

Gilead Sciences develops and sells medicines, mainly HIV treatments such as Biktarvy and Descovy, alongside hepatitis therapies, CAR T-cell cancer treatments including Yescarta and Tecartus, and the antiviral Veklury used against COVID-19. It runs research partnerships with several biotech firms to widen its pipeline in oncology and immunology.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the GILD overview. Research diary readings, not advice.

Uptrend stack intact

Trades +14.6% vs the 50-day and +24.3% vs the 200-day average, 0.7% below the 52-week high and +50.8% off the 52-week low; a golden cross printed 50 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the GILD chart & overview · the signal board

FAQ · from the current data · as of 2026-11-04

Quick answers

What is the current Closelooknet signal on GILD?

Uptrend stack intact — Trades +14.6% vs the 50-day and +24.3% vs the 200-day average, 0.7% below the 52-week high and +50.8% off the 52-week low; a golden cross printed 50 sessions ago. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is GILD above its 50-day and 200-day moving averages?

As of 2026-11-04, Gilead Sciences Inc trades +14.6% above its 50-day and +24.3% above its 200-day average, with the 20-day +10.2% away.

How far is GILD from its 52-week high?

0.7% below the 52-week high and 50.8% above the 52-week low, as of 2026-11-04.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.